COMPASS PATHWAYS PLC (CMPS) Fundamental Analysis & Valuation

NASDAQ:CMPS • US20451W1018

Current stock price

9.15 USD
+0.4 (+4.57%)
At close:
9.16 USD
+0.01 (+0.11%)
After Hours:

This CMPS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CMPS Profitability Analysis

1.1 Basic Checks

  • CMPS had negative earnings in the past year.
  • CMPS had a negative operating cash flow in the past year.
  • CMPS had negative earnings in each of the past 5 years.
  • In the past 5 years CMPS always reported negative operating cash flow.
CMPS Yearly Net Income VS EBIT VS OCF VS FCFCMPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M -200M -250M

1.2 Ratios

  • CMPS's Return On Assets of -136.85% is on the low side compared to the rest of the industry. CMPS is outperformed by 81.20% of its industry peers.
Industry RankSector Rank
ROA -136.85%
ROE N/A
ROIC N/A
ROA(3y)-84.12%
ROA(5y)-64.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CMPS Yearly ROA, ROE, ROICCMPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 400

1.3 Margins

  • CMPS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CMPS Yearly Profit, Operating, Gross MarginsCMPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. CMPS Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for CMPS has been increased compared to 1 year ago.
  • The number of shares outstanding for CMPS has been increased compared to 5 years ago.
  • Compared to 1 year ago, CMPS has a worse debt to assets ratio.
CMPS Yearly Shares OutstandingCMPS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CMPS Yearly Total Debt VS Total AssetsCMPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • CMPS has an Altman-Z score of -5.92. This is a bad value and indicates that CMPS is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CMPS (-5.92) is worse than 66.86% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.92
ROIC/WACCN/A
WACCN/A
CMPS Yearly LT Debt VS Equity VS FCFCMPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

  • A Current Ratio of 0.77 indicates that CMPS may have some problems paying its short term obligations.
  • CMPS has a Current ratio of 0.77. This is amonst the worse of the industry: CMPS underperforms 89.53% of its industry peers.
  • CMPS has a Quick Ratio of 0.77. This is a bad value and indicates that CMPS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.77, CMPS is not doing good in the industry: 89.15% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.77
CMPS Yearly Current Assets VS Current LiabilitesCMPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. CMPS Growth Analysis

3.1 Past

  • The earnings per share for CMPS have decreased strongly by -40.43% in the last year.
EPS 1Y (TTM)-40.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-58.73%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 16.25% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y46.16%
EPS Next 2Y26.61%
EPS Next 3Y20.24%
EPS Next 5Y16.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CMPS Yearly Revenue VS EstimatesCMPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
CMPS Yearly EPS VS EstimatesCMPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

1

4. CMPS Valuation Analysis

4.1 Price/Earnings Ratio

  • CMPS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year CMPS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CMPS Price Earnings VS Forward Price EarningsCMPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CMPS Per share dataCMPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -1 -2 -3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CMPS's earnings are expected to grow with 20.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.61%
EPS Next 3Y20.24%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CMPS Dividend Analysis

5.1 Amount

  • No dividends for CMPS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CMPS Fundamentals: All Metrics, Ratios and Statistics

COMPASS PATHWAYS PLC

NASDAQ:CMPS (4/23/2026, 8:00:10 PM)

After market: 9.16 +0.01 (+0.11%)

9.15

+0.4 (+4.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-24
Earnings (Next)05-06
Inst Owners46.12%
Inst Owner Change0.17%
Ins Owners1.49%
Ins Owner Change3.05%
Market Cap1.18B
Revenue(TTM)N/A
Net Income(TTM)-287.86M
Analysts83.33
Price Target22.19 (142.51%)
Short Float %7.53%
Short Ratio2.76
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-205.28%
Min EPS beat(2)-261.99%
Max EPS beat(2)-148.58%
EPS beat(4)2
Avg EPS beat(4)-96.03%
Min EPS beat(4)-261.99%
Max EPS beat(4)20.36%
EPS beat(8)4
Avg EPS beat(8)-49.22%
EPS beat(12)6
Avg EPS beat(12)-39.3%
EPS beat(16)9
Avg EPS beat(16)-25.66%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.8%
PT rev (3m)29.32%
EPS NQ rev (1m)12.71%
EPS NQ rev (3m)17.56%
EPS NY rev (1m)-1.79%
EPS NY rev (3m)-2.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.23
EYN/A
EPS(NY)-1.74
Fwd EYN/A
FCF(TTM)-1.22
FCFYN/A
OCF(TTM)-1.22
OCFYN/A
SpS0
BVpS-0.41
TBVpS-0.41
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -136.85%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-84.12%
ROA(5y)-64.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.77
Altman-Z -5.92
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-58.73%
EPS Next Y46.16%
EPS Next 2Y26.61%
EPS Next 3Y20.24%
EPS Next 5Y16.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-25.73%
EBIT Next 3Y15.97%
EBIT Next 5Y40.94%
FCF growth 1Y-31.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.93%
OCF growth 3YN/A
OCF growth 5YN/A

COMPASS PATHWAYS PLC / CMPS Fundamental Analysis FAQ

What is the fundamental rating for CMPS stock?

ChartMill assigns a fundamental rating of 0 / 10 to CMPS.


What is the valuation status for CMPS stock?

ChartMill assigns a valuation rating of 1 / 10 to COMPASS PATHWAYS PLC (CMPS). This can be considered as Overvalued.


How profitable is COMPASS PATHWAYS PLC (CMPS) stock?

COMPASS PATHWAYS PLC (CMPS) has a profitability rating of 0 / 10.